
|Articles|June 3, 2006
NCI mulls genetic risk of prostate, breast cancer
Future cancer management may rely on identifying healthy individuals at risk before they develop symptoms of disease, according to National Cancer Institute researchers.
Advertisement
Future cancer management may rely on identifying healthy individuals at risk before they develop symptoms of disease, according to National Cancer Institute researchers.
The NCI has launched an initiative to identify genetic alterations that create susceptibility to prostate and breast cancer. The three-year, $14 million Cancer Genetic Markers of Susceptibility project will begin by scanning 2500 genetic samples from men who have been diagnosed with prostate cancer as well as a control group. Data will be available via the NCI.
Advertisement
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Diagnostic Imaging’s Weekly Scan: June 14 — June 20
2
What a Meta-Analysis Reveals About FAPI PET/CT for Detection of Peritoneal Metastases
3
Emerging PET Radiotracer May Enhance Detection of Small Metastases in Patients with Advanced Melanoma
4
Molecular Imaging in Focus: Key Takeaways from the 2026 SNMMI Conference with Michael Hofman, MBBS, FRACP
5














